25 results for “retinopathy”. Showing 25 of 39,449.
Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
retinopathy, vision-threatening diabetic retinopathy, possible glaucoma, and age-related
Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies.
retinopathies such as glaucoma, retinoblastoma, and age-related macular degeneration
Aberrant STING signalling promotes endothelial dysfunction and neurovascular injury in diabetic retinopathy.
retinopathy is a common complication of diabetes mellitus that is characterised
Natural diterpenoid EKO activates deubiqutinase ATXN3 to preserve vascular endothelial integrity and alleviate diabetic retinopathy through c-fos/focal adhesion axis.
retinopathy (DR) is one of the most prevalent severe diabetic
Suppression of connexin 43 phosphorylation promotes astrocyte survival and vascular regeneration in proliferative retinopathy.
retinopathies. However, the molecular events that underlie astrocyte loss remain
Hydroxycarboxylic acid receptor 2 (GPR109A) and retinopathies: pathways and prospects.
retinopathy (HR) and retinopathy of prematurity (ROP), where inflammation, oxidative
Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
retinopathy. Whereas therapies targeting vascular endothelial growth factor A (VEGFA
Neuronal Dysfunction Is Linked to the Famine-Associated Risk of Proliferative Retinopathy in Patients With Type 2 Diabetes.
retinopathy (PDR) in adulthood. However, the underlying mechanisms are not known
Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
retinopathy is characterised by retinal neurodegeneration and retinal vascular abnormalities
Integration of multi-omics transcriptome-wide analysis for the identification of novel therapeutic drug targets in diabetic retinopathy.
retinopathy (DR) is the most important complication of Type 2 Diabetes
Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury.
retinopathy is a hallmark finding of common visual disorders including
Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy.
retinopathy (DR) is one of the leading causes of blindness
Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologies.
retinopathy (DR). DR development involves dysregulation of the polyol pathway
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis.
retinopathy (DR) and retinopathy of prematurity, which are the leading
Targeting neurotrophic dysregulation in diabetic retinopathy: a novel therapeutic avenue.
retinopathy (DR), and it is the main cause of visual
Somatostatin replacement: a new strategy for treating diabetic retinopathy.
retinopathy (DR) has been classically considered to be a microcirculatory
YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2.
retinopathy is a precipitating factor for retinal neovascularization, lactylation is very
Single-Cell Transcriptome Profiling Reveals the Suppressive Role of Retinal Neurons in Microglia Activation Under Diabetes Mellitus.
retinopathy, as one of the common complications of diabetes mellitus
Artificial intelligence in ophthalmology.
retinopathy, glaucoma, and cataracts. The more common occurrence of these
Somatostatin replacement: a new strategy for treating diabetic retinopathy.
retinopathy (DR) has been classically considered to be a microcirculatory
Classification of diabetic retinopathy: Past, present and future.
retinopathy (DR) is a leading cause of visual impairment and blindness
Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.
retinopathy (DR) is a neurovascular complication of diabetes. Recent investigations
Update in the molecular mechanism and biomarkers of diabetic retinopathy.
retinopathy (DR) is a serious complication of diabetes caused by long
Glial cell alterations in diabetes-induced neurodegeneration.
retinopathy, peripheral neuropathy, and cognitive decline, are intimately associated with
Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach.
retinopathy (DR), the most common microvascular complication of diabetes. Additionally